103 related articles for article (PubMed ID: 2651867)
1. New findings in obsessive-compulsive disorder.
Kim SW; Dysken MW
Minn Med; 1989 Feb; 72(2):91-3, 110. PubMed ID: 2651867
[TBL] [Abstract][Full Text] [Related]
2. Serotonin selectivity for obsessive compulsive and panic disorders.
Montgomery SA; Bullock T; Fineberg N
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
[No Abstract] [Full Text] [Related]
3. Symptom relapse in bulimia nervosa and obsessive compulsive disorder after treatment with serotonin antagonists.
Hollander E; Mullen LS; Carrasco JL; DeCaria CM; Stein DJ
J Clin Psychiatry; 1992 Jan; 53(1):28. PubMed ID: 1737737
[No Abstract] [Full Text] [Related]
4. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
Zak JP; Miller JA; Sheehan DV; Fanous BS
J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and treatment in obsessive-compulsive disorder.
March JS; Gutzman LD; Jefferson JW; Greist JH
Psychiatr Dev; 1989; 7(1):1-18. PubMed ID: 2508084
[TBL] [Abstract][Full Text] [Related]
6. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
Murphy DL; Zohar J; Benkelfat C; Pato MT; Pigott TA; Insel TR
Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
Kamijima K; Aoki M
Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
9. Obsessive-compulsive disorder and its treatment with serotonin-selective agents.
Murphy DL; Pigott TA
Prog Clin Biol Res; 1990; 361():179-201. PubMed ID: 2290841
[No Abstract] [Full Text] [Related]
10. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
McDougle CJ; Goodman WK; Leckman JF; Price LH
Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
[TBL] [Abstract][Full Text] [Related]
11. [Drug treatment of compulsive disorder].
Rapoport JL
Nervenarzt; 1991 May; 62(5):318-20. PubMed ID: 1865964
[No Abstract] [Full Text] [Related]
12. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
Salmerón JM; Alcántara AG; Barcia D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):399-402. PubMed ID: 9972593
[TBL] [Abstract][Full Text] [Related]
13. Animal models in obsessive compulsive disorder.
Olivier B
Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():27-9. PubMed ID: 1517553
[No Abstract] [Full Text] [Related]
14. [The role of drugs in the treatment of obsessive-compulsive disorders].
den Boer JA; Westenberg HG
Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405
[No Abstract] [Full Text] [Related]
15. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
Sevincok L; Topuz A
J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
[TBL] [Abstract][Full Text] [Related]
16. Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder.
Laird LK
Psychopharmacol Bull; 1996; 32(4):569-78. PubMed ID: 8993077
[TBL] [Abstract][Full Text] [Related]
17. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
Korff S; Harvey BH
Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder.
Gráf M
Neuropsychopharmacol Hung; 2006 Mar; 8(1):23-8. PubMed ID: 16841562
[TBL] [Abstract][Full Text] [Related]
19. [Schizophrenic with obsessive-compulsive disorder or symptoms].
Doubremelle C; Millet B; Olie JP
Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic antidepressants and obsessive-compulsive disorder.
Cialdella P; Boissel JP
Am J Psychiatry; 1991 Oct; 148(10):1415-6. PubMed ID: 1832819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
